LEXICON PHARMACEUTICALS, INC. (LXRX) Corporate Subsidiaries
LEXICON PHARMACEUTICALS, INC. (LXRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LXRX
CIK: 1062822
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerChase Gentry
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-08-14 | — | EFFECT Filing | 9999999995-26-002666 | View SEC Doc Filr Page |
| S-3 | 2026-08-06 | — | S-3 | 0001193125-26-338409 | View SEC Doc Filr Page |
| S-8 | 2026-08-06 | — | S-8 | 0001062822-26-000119 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001062822-26-000117 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002060 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001062822-26-000112 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | PRIMARY DOCUMENT | 0001062822-26-000108 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | PRIMARY DOCUMENT | 0001062822-26-000107 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | PRIMARY DOCUMENT | 0001062822-26-000106 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | PRIMARY DOCUMENT | 0001062822-26-000105 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | PRIMARY DOCUMENT | 0001062822-26-000104 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | PRIMARY DOCUMENT | 0001062822-26-000103 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | PRIMARY DOCUMENT | 0001062822-26-000102 | View SEC Doc Filr Page |
| 4 | 2026-05-08 | 2026-04-30 | 4 | 0001193125-26-215297 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-08 | — | SCHEDULE 13D/A Filing | 0001193125-26-215295 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001062822-26-000101 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001062822-26-000098 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-04 | 8-K | 0001062822-26-000094 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | PRIMARY DOCUMENT | 0001062822-26-000092 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | PRIMARY DOCUMENT | 0001062822-26-000090 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | PRIMARY DOCUMENT | 0001062822-26-000084 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | PRIMARY DOCUMENT | 0001062822-26-000082 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | PRIMARY DOCUMENT | 0001062822-26-000080 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | PRIMARY DOCUMENT | 0001062822-26-000075 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | PRIMARY DOCUMENT | 0001062822-26-000067 | View SEC Doc Filr Page |